Literature DB >> 637423

Continuous ambulatory peritoneal dialysis.

R P Popovich, J W Moncrief, K D Nolph, A J Ghods, Z J Twardowski, W K Pyle.   

Abstract

The technique of continuous ambulatory peritoneal dialysis was evaluated in nine patients during 136 patient weeks. The major objectives were to see if continuous ambulatory peritoneal dialysis would provide [1] acceptable control of serum chemistries by usual criteria, [2] adequate removal of sodium and water, [3] tolerable protein losses, and [4] a low prevalence of peritonitis with episodes responsive to therapy with continuing continuous ambulatory peritoneal dialysis. Preliminary findings suggest continuous ambulatory peritoneal dialysis represents an effective ambulatory, portable, internal dialysis technique. Larger-solute clearances per week may approach values six times greater than with most hemodialysis techniques. Small-solute clearances approach dialysate flow rate (8.3 ml/min) and are comparable to other dialysis techniques on a weekly basis. Edema is readily controlled and protein losses should be tolerable with adequate protein intake. Peritonitus occurs on the average every 10 weeks but responds to therapy promptly with continuing continuous ambulatory peritoneal dialysis. If the prevalence of peritonitis can be reduced, continuous ambulatory peritoneal dialysis appears to represent a very attractive dialysis technique.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637423     DOI: 10.7326/0003-4819-88-4-449

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  71 in total

1.  Catheter types and their abdominal implantation in peritoneal dialysis.

Authors:  A Karátson; L Rácz; I Buzogány
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R H Barbhaiya; C A Knupp; M Pfeffer; D Zaccardelli; G M Dukes; W Mattern; K A Pittman; L J Hak
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

3.  Risk factors associated with peritoneal dialysis catheter survival: a 9-year single-center study in 315 patients.

Authors:  Namita Singh; Ingemar Davidson; Abu Minhajuddin; Steven Gieser; Michael Nurenberg; Ramesh Saxena
Journal:  J Vasc Access       Date:  2010 Oct-Dec       Impact factor: 2.283

Review 4.  Peritoneal Metastases from Gastrointestinal Cancer.

Authors:  Paul H Sugarbaker
Journal:  Curr Oncol Rep       Date:  2018-06-08       Impact factor: 5.075

5.  Introduction of a new laparoscopic trocar for insertion of peritoneal dialysis catheters and making a proper rectus sheath tunneling.

Authors:  Amir Keshvari; Mohammad Reza Keramati; Mohammad Reza Nassajian; Mehrzad Mohsenipour; Mohammad Kazem Nouritaromlou
Journal:  Surg Endosc       Date:  2016-04-08       Impact factor: 4.584

6.  Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

Authors:  H A Verbrugh; W F Keane; W E Conroy; P K Peterson
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Continuous ambulatory peritoneal dialysis in a program for children with end stage renal disease.

Authors:  R S Fennell; J K Orak; T Hudson; E H Garin; A Iravani; G A Richard; S L Hislop; M I Knight
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

9.  Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  S Pancorbo; C Comty
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Biochemical studies on patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  V W Armstrong; C Fuchs; F Scheler
Journal:  Klin Wochenschr       Date:  1980-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.